if you look at the unaudited our loss is getting better

New Post Public Reply Private Reply Replies (0) Message Board

Aug 9, 2013 at 10:14 PM

if you look at the unaudited our loss is getting better year over year ,quarter over quarter. we are headed for profitability here this was put out before all of the debit cancelations we now have.
If you look at the first statement here it shows our lose is less on each year and quarter over quarter. these are unaudited statements we are looking at here.

Medical Alarm Concepts Holding, Inc.
CONSOLIDATED STATEMENTS
OF OPERATIONS
(Unaudited)		Year End Fiscal			Year End Fiscal			Quarter Ending			Quarter Ending
		June 30, 2011			June 30, 2012			September 30, 2012			December 31, 2012

Revenue	$	452,110		$	573,472		$	95,426		$	102,280
Cost of Sales		148,877			322,795			27,182			78,599

Gross Profit	$	303,233		$	250,678		$	68,244		$	23,681

Operating Expenses
Advertising and Marketing		599,032			98,472			56,672			43,892
Amortization		416,667			416,667			104,167			104,167
Compensation		52,470			47,184			33,000			26,798
Depreciation		5,249			5,250			1,312			1,312
General and Administrative		209,695			183,442			37,433			41,625
Professional Fees		135,320			139,737			14,788			16,164
Research and Development		108,742			18,300			30,000			836
Travel and Entertainment		46,598			33,434			5,804			5,817
Total Operating Expenses	$	1,573,773		$	942,485		$	283,176		$	240,611

Loss from Operations	$	(1,270,540	)	$	(691,807	)	$	(214,932	)	$	(216,930	)

Other Income (Expenses)								(40,000	)
Gain (loss) on Derivative Liabilities		697,429
Interest for Patent					110,000			50,000			27,500
Interest Income (Expense)		(251,967	)		18,500

Total Other income (Expense)		445,462			128,500			(90,000	)		(27,500	)

income (Loss) Before Income Taxes	$	(825,078	)	$	(820,307	)	$	(304,932	)	$	(244,430	)

Provision for Income Tax

Net Income (Loss)	$	(825,078	)	$	(820,307	)	$	(304,932	)	$	(244,430	)

Medical Alarm Concepts Holding, Inc.
CONSOLIDATED BALANCE SHEET
		December 31, 2012
		(Unaudited)
Current Assets
Cash and on Deposit at Vendors	$	93,153
Restricted Cash		(265	)
Account Receivable		58,514
Un-deposited Funds		3,796
Allowance for Bad Debt		(12,855	)
Inventory		52,042
Loan Receivable		100,000
Payroll Exchange		1,907
Total Current Assets	$	196,265
Fixtures		20,000
Office Equipment		11,964
Accum. Depreciation		(23,625	)
Patent		2,500,000
Amort. of Patent		(1,874,998	)
Shareholders Loans		49,508

Total Assets	$	879,115
Current Liabilities
Accounts Payable		86,348
Unapplied Cash		1,299
Unapplied Credit		4,393
Accrued Expenses		12,005
Taxes Payable		18,895
Due to Officer		43,011
Prepay to AR		0
Def Revenue		240,500
Common Stock to be Issued		15,000
Total Current Liabilities	$	421,451

Long Term Liabilities
Derivative Liabilities - Warrants		393,380
Note to Biotech		472,794
Note Payable - Long Term		2,500,000
Note Payable - Investors		346,921

Total Liabilities	$	4,134,546

Equity
Paid in Capital		5,359,169
Common Stock		122,256
Retained Earnings		(22,654,050	)
Retained Earnings - CPC		14,936,987
Preferred Stock		55
Preferred Stock Series B		995
Net Income (Loss Current Fiscal		(1,021,383	)
Total Liabilities & Equity	$	878,576


Medical Alarm Concepts Holding, Inc.
CONSOLIDATED STATEMENTS OF OPERATIONS

		Nine Months			Three Month Ending			Year End Fiscal
		March 31, 2011			June 1, 2011			June 30, 2011
		(Unaudited)			(Unaudited)			(Unaudited)
Revenue	$	418,776		$	33,334		$	452,110
Cost of Sales		147,115			1,762			148,877

Gross Profit		271,661			31,572			303,233
Operating Expenses
Advertising and Marketing		596,137			2,895			599,032
Amortization		312,500			104,167			416,667
Compensation		52,470						52,470
Depreciation		3,937			1,312			5,249
General and Administrative		174,492			35,203			209,695
Professional Fees		138,165			(2,845	)		135,320
Research and Development		74,280			34,462			108,742
Travel and Entertainment		42,503			4,095			46,598
Total Operating Expenses		1,394,492			179,289			1,573,773
Loss from Operations	$	1,122,381	)	$	147,717	)	$	1,270,540	)
Other Income (Expenses)
Gain (loss) on Derivative Liabilities		697,429						697,429
Other Expense
Interest Income (Expense)		(214,467	)		(37,500	)		(251,967	)

Total Other income (Expense)		482,962			(37,500	)		445,462

Income (Loss) Before Taxes	$	(639,869	)	$	(185,217	)	$	(825,078	)

Provision for Income Tax

Net Income (Loss)	$	(639,869	)	$	(185,217	)	$	(825,078	)
Net Income (loss) Per share		(0	)

Average Common Shares		247,132,983


Medical Alarm Concepts Holding, Inc.
CONSOLIDATED BALANCE SHEET

		June 30, 2011
		(Unaudited )

Current Assets
Cash	$	(794	)
Restructured Cash		(265	)
Account Receivable		24,035
Allowance for Bad Debt		(12,855	)
Inventory		22,462
Payroll Exchange		1,907

Total Current Assets	$	34,491

Fixtures		20,000
Office Equipment		11,964
Accum. Depreciation		(15,750	)
Patent		2,500,000
Amort. of Patent		(1,249,998	)
Shareholders Loans		49,508

Total Assets	$	1,350,215

Liabilities
Accounts Payable		188,630
Unapplied Cash		709
Unapplied Credit		4,852
Taxes Payable		18,895
Due to Officer		43,011
Def Reveues		80,998
Derivative Liabilities - Warrants		393,380
Common Stock to be Issued		15,000
Note Payable - Long Term		2,500,000
Note Payable - Investors		298,456

Total Liabilities	$	3,543,930

Equity
Paid in Capital	$	5,212,540
Common Stock		32,761
Retained Earnings		(22,112,181	)
Retained Earnings - CPC		14,936,987
Preferred Stock		55
Preferred Stock Series B		995
Net Income (Loss Current Fiscal		(264,872	)

Total Liabilities & Equity	$	1,350,215

Medical Alarm Concepts Holding, Inc.
CONSOLIDATED STATEMENTS OF OPERATIONS

	Year End Fiscal
	June 30, 2012
		(unaudited )

Revenue	$	573,472
Cost of Sales		323,795

Gross Profit	$	249,833

Operating Expenses
Advertising and Marketing		98,472
Amortization		416,667
Compensation		21,950
Depreciation		5,250
General and Administrative		325,757
Professional Fees		32,998
Research and Development		18,300
Travel and Entertainment		31,457
Total Operating Expenses		950,850

Loss from Operations	$	(701,018	)

Other Income (Expenses)		125,001
Gain (loss) on Derivative Liabilities
Interest for Patent		154,500
Interest Income (Expense)		18,500

Total Other income (Expense)		(47,999	)

income (Loss) Before Income Taxes	$	(749,017	)

Provision for Income Tax		0

Net Income (Loss)	$	(749,017	)

Medical Alarm Concepts Holding, Inc.
CONSOLIDATED BALANCE SHEET
		June 30, 2012
		(Unaudited)
Current Assets
Cash and on Deposit at Vendors	$	120,978
Restricted Cash		(265	)
Account Receivable		16,970
Undeposited Funds		3,967
Allowance for Bad Debt		(12,855	)
Inventory		52,042
Loan Receivable		100,000
Payroll Exchange		1,907
Total Current Assets	$	282,744
Fixtures		20,000
Office Equipment		11,964
Accum. Depreciation		(21,000	)
Patent		2,500,000
Amort. of Patent		(1,666,664	)
Shareholders Loans		49,508

Total Assets	$	1,176,551

Liabilities
Accounts Payable		67,285
Unapplied Cash		1,203
Unapplied Credit		4,393
Accrued Expenses		12,005
Taxes Payable		18,895
Due to Officer		43,011
Prepay to AR		228
Total Current Liabilities	$	147,020

Long Term Notes		465,294
Def Revenue		103,945
Derivative Liabilities - Warrants		393,380
Common Stock to be Issued		15,000
Note Payable - Long Term		2,500,000
Note Payable - Investors		312,471
Total Long Term Liabilities	$	3,790,089

Total Liabilities	$	3,937,109

Equity
Paid in Capital		5,328,769
Common Stock		98,706
Retained Earnings		(22,654,050	)
Retained Earnings - CPC		14,936,987
Preferred Stock		55
Preferred Stock Series B		995
Net Income (Loss Current Fiscal		(472,020	)

Total Liabilities & Equity	$	1,176,551

Medical Alarm Concepts Holding, Inc.
CONSOLIDATED STATEMENTS OF OPERATIONS

	Fiscal Quarter Ending
	September 30, 2012
		( Unaudited )
Revenue	$	95,426
Cost of Sales		27,182

Gross Profit	$	68,244

Operating Expenses
Advertising and Marketing		56,672
Amortization		104,167
Compensation		33,000
Depreciation		1,312
General and Administrative		37,433
Professional Fees		14,788
Research and Development		30,000
Travel and Entertainment		5,804
Total Operating Expenses		283,176

Loss from Operations	$	(214,932	)

Other Income (Expenses)		(40,000	)
Gain (loss) on Derivative Liabilities
Interest for Patent		50,000
Interest Income (Expense)

Total Other income (Expense)		(90,000	)

income (Loss) Before Income Taxes	$	(304,932	)

Provision for Income Tax		0

Net Income (Loss)	$	(304,932	)

Medical Alarm Concepts Holding, Inc.
CONSOLIDATED BALANCE SHEET
		September 30, 2012
		(Unaudited)
Current Assets
Cash and on Deposit at Vendors	$	103,258
Restricted Cash		(265	)
Account Receivable		62,462
Undeposited Funds		3,769
Allowance for Bad Debt		(12,855	)
Inventory		52,042
Payroll Exchange		1,907
Total Current Assets	$	210,318
Fixtures		20,000
Office Equipment		11,964
Accum. Depreciation		(22,312	)
Patent		2,500,000
Amort. of Patent		(1,770,831	)
Shareholders Loans		49,508

Total Assets	$	998,647

Liabilities
Accounts Payable		71,497
Unapplied Cash		1,323
Unapplied Credit		4,932
Accrued Expenses		12,005
Taxes Payable		18,895
Due to Officer		43,011
Prepay to AR		37
Total Current Liabilities	$	151,700

Long Term Notes		299,640
Def Revenues		170,642
Derivative Liabilities - Warrants		393,380
Common Stock to be Issued		15,000
Note Payable - Long Term		2,500,000
Note Payable - Investors		472,794
Total Long Term Liabilities	$	3,851,456

Total Liabilities	$	4,000,687

Equity
Paid in Capital		5,368,669
Common Stock		122,256
Retained Earnings		(22,654,050	)
Retained Earnings - CPC		14,936,987
Preferred Stock		55
Preferred Stock Series B		995
Net Income (Loss Current Fiscal		(776,953	)

Total Liabilities & Equity	$	998,647

Read more: http://www.faqs.org/sec-filings/130212/MEDICA...z2bWnsbpbS

Wearable Health Solutions, Inc (WHSI) Stock Research Links

WHSI Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

D-Wave's Legal Trouble: Securities Fraud Suit Looms

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Novo's Semaglutide Shows Promise in MASH Study

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

GlycoNex Eyes Japanese Market with Denosumab Biosimilar

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Fibocom LTE Modules Test Drive Satellite Connectivity

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Innovent's SINTBILO® Hits Primary Endpoint in Study

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...